Companies / Evelo Biosciences, Inc.
Evelo Biosciences, Inc.
EVLOCIK 1694665
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| May 27, 2022 | Flagship Ventures Fund IV General Partner LLC 10% owner | Buy Open-market buy | Common Stock | $20.00M | +13.7M | 13,698,630 | high |
| May 27, 2022 | Flagship Ventures Fund IV General Partner LLC 10% owner | Buy Open-market buy | Common Stock | $10.00M | +6.8M +499.78% | 8,219,791 | high |
| Jul 11, 2023 | Flagship Ventures Fund IV General Partner LLC 10% owner | Buy Open-market buy | Common Stock | $7.50M | +3.2M +474.03% | 3,931,685 | high |
| May 27, 2022 | Flagship Ventures Fund IV General Partner LLC 10% owner | Buy Open-market buy | Common Stock | $6.40M | +4.4M +136.67% | 7,590,873 | high |
| Jul 11, 2023 | Flagship Ventures Fund IV General Partner LLC 10% owner | Buy Open-market buy | Common Stock | $2.50M | +1.1M +263.33% | 1,493,241 | high |
| Jul 11, 2023 | Flagship Ventures Fund IV General Partner LLC 10% owner | Buy Open-market buy | Common Stock | $2.50M | +1.1M +285.15% | 1,461,795 | high |
| May 27, 2022 | Flagship Ventures Fund IV General Partner LLC 10% owner | Buy Open-market buy | Common Stock | $2.00M | +1.4M +33.21% | 5,495,324 | high |
| May 27, 2022 | Flagship Ventures Fund IV General Partner LLC 10% owner | Buy Open-market buy | Common Stock | $1.60M | +1.1M +138.45% | 1,887,419 | high |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| EVLO | common | 299734202 |